Patent directory Β· USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code β or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 12213996
Methods of treating optic nerve diseases using neural progenitor cell growth factors
granted -
US 12214015
Use of c-type natriuretic peptide variants to treat osteoarthritis
granted -
US 12213973
Bacterial nitric oxide synthase inhibitors
granted -
US 12213989
Use of maribavir in treatment regimens
granted -
US 12214023
Compositions and methods for expressing factor IX
granted -
US 12214021
Study on lactoferrin regulation of bone formation by means of vitamin D receptor
granted -
US 12214014
Methods for scar reduction by converting scar fibroblasts into adipocytes with hair follicle-derived signals
granted -
US 12214061
Adhesive composition for dental use
granted -
US 12215131
IgG Fc-IL2-RΞ±-IL2 fusions and methods of use thereof
granted -
US 12215164
Immunotoxins with albumin binding domain
granted -
US 12215138
Compositions and methods for internalizing enzymes
granted -
US 12215105
HPK1 antagonists and uses thereof
granted -
US 12219327
Substituted isoindolines as PI3K-alpha inhibitors
granted -
US 12213985
Oral cannabinoid formulations
granted -
US 12213998
Adipose tissue-derived stromal stem cells for use in treating refractory complex perianal fistulas in Crohn's disease
granted -
US 12213977
Methods and compositions for treating melanoma
granted -
US 12214002
Compositions and methods for treating antibiotic resistance
granted -
US 12213964
Isoxazoline parasiticide formulations
granted -
US 12213951
Treatment of autism with cannabidiol
granted -
US 12214218
Perfusion modulated tumor dose sculpting with single dose radiotherapy
granted -
US 12215343
Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
granted -
WO 2025023852
ANTAGONISTES DU RΓCEPTEUR DE L'OREXINE MORPHOLINE
granted -
WO 2025023851
ANTAGONISTES DU RΓCEPTEUR DE L'OREXINE MORPHOLINE
granted -
US 2025034157
PROCESSES FOR THE PREPARATION OF (3S,4R)-3-ETHYL-4-(3H-IMIDAZO[1,2-a]PYRROLO[2,3-e]-PYRAZIN-8-YL)-N-(2,2,2-TRIFLUOROETHYL)PYRROLIDINE-1-CARBOXAMIDE AND SOLID STATE FORMS THEREOF
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search β best for looking up a specific filing or applicant portfolio slice.